COMING UP NEXT ON ARIZONA HORIZON:WILDFIRES IN CALIFORNIA ARE CAUSING SOME SUPPLY-CHAIN ISSUES THAT COULD IMPACT ARIZONA.

ALSO TONIGHT: CONCERNS OVER AN INCREASE IN CASES OF THE RESPIRATORY-VIRUS HMPV.

AND, A PROMISING NEW APPROACH IN TREATING AN AGGRESSIVE FORM OF BRAIN CANCER.

THOSE STORIES AND MORE, NEXT, ON ARIZONA HORIZON.

>> GOOD EVENING AND WELCOME TO ARIZONA HORIZON.

I'M TED SIMONS.

THE CEASEFIRE DEAL BETWEEN ISRAEL AND HAMAS ANNOUNCED YESTERDAY IS NOT A "DONE" DEAL AS OF TODAY.DISPUTES INCLUDE HOW ISRAELI FORCES WOULD DEPLOY ALONG GAZA'S BORDER WITH EGYPT AND DEMANDS BY HAMAS FOR THE RELEASE OF CERTAIN PRISONERS HELD BY ISRAEL.

AS FOR BROKERING THE DEAL, OUTGOING SECRETARY OF STATE ANTONY BLINKEN WAS ASKED HOW MUCH THE "INCOMING" TRUMP ADMINISTRATION HELPED WITH THE AGREEMENT.

>> EVERYTHING WILL BE IMPLEMENTED UNDER THE TRUMP ADMINISTRATION.

IT WAS IMPORTANT FOR THE PARTIES TO KNOW THE TRUMP ADMINISTRATION STOOD BEHIND THE AGREEMENT THE SENATE BEING VERY CLEAR WITH ALL CONCERN THAT THE INCOMING ADMINISTRATION SUPPORTED, ENDORSED, AND WOULD CARRY FORWARD THEIR RESPONSIBILITIES UNDER THE AGREE.

>> RATIFICATION BY THE ISRAELI CABINET IS NOT EXPECTED UNTIL SATURDAY AT THE EARLIEST.

>>> MORE CONFIRMATION HEARINGS FOR NOMINEES LEE, THE LEE ZELDIN, THE CHOICE TO LEADS THE ENVIRONMENTAL PROTECTION AGENCY, WAS PRESSED ON CLIMATE CHANGE.

>> DO YOU BELIEVE CLIMATE CHANGES IS A HOAX?

>> I BELIEVE IT WAS REAL AS I TOLD YOU.

AS FOR AS PRESIDENT TRUMP, HE SPOKE ABOUT CRITICISM OF POLICIES THAT HAD BEEN ENACTED BECAUSE OF CLIMATE CHANGE.

HE'S CONCERNED ABOUT ECONOMIC COSTS AND DIFFERENCE OF OPINION.

>> I WOULD RESPECTFULLY DISAGREE.

HE CALLED IT A HOAX TIME AND TIME AGAIN.

ALSO TODAY, THE NOMINEE FOR TREASURY SECRETARY, SCOTT BESSENT, WAS ASKED ABOUT INFLATION AT "HIS" CONFIRMATION HEARING.

>> YOU BELIEVE HIS POLICIES WILL INCREASE WAGES AND LOWER INFLATION.

>> YES, CLOSER TO THE RESERVES 2% TARGET AS IT DID DURING THE FIRST ADMINISTRATION.

>> WINDS AND WILDFIRES IN LOS ANGELES EASED TODAY, BUT MANY EVACUATION ORDERS ARE STILL IN EFFECT AND SOME OF THOSE EVACUATED MANY NOT BE ABLE TO RETURN FOR AT LEAST ANOTHER WEEK.

AND THERE ARE CONCERNS ONCE THE 2- MAJOR BURN AREAS START SEEING RAIN.

>> THE PROPERTIES HAVE BEEN DAMAGED BEYOND BELIEF.

THEY ARE FULL OF SEDIMENT, DEBRIS, SILT, AND HAZARDOUS MATERIALS.

THEY ARE ASSESSING THE IMPACT OF THE FLOOD CONTROL SYSTEM BOTH SUFFERED BURN AREAS WHERE WE WILL SEE MASSIVE DEBRIS.

>> THE THREAT OF FLOODS AND LANDSLIDES WILL CONTINUE FOR MONTHS AND IN SOME CASES YEARS.

AND FINALLY, BOB UECKER HAS DIED.

IT WAS CANCER.

HE WAS 90.

BOB UECKER WAS A MEDIOCRE BASEBALL PLAYER WHO TURNED HIS LESS THAN STELLAR PLAYING SKILLS INTO A HALL-OF-FAME CAREER AS A COMIC, AN ACTOR AND THE BELOVED PLAY-BY-PLAY VOICE FOR THE MILWAUKEE BREWERS.

VERY FUNNY MAN WHO BROUGHT JOY TO A LOT OF FOLKS.

BOB UECKER, DEAD, AT 90.>>> THE WILDFIRES IN SOUTHERN CALIFORNIA ARE MAKING FOR SUPPLY- CHAIN CONCERNS, INCLUDING TRANSPORTATION DELAYS TO AND FROM L-A-X AND THE PORTS OF LONG BEACH AND LOS ANGELES.JOINING US NOW IS DALE ROGERS, FROM ASU'S W.P.

CAREY SCHOOL OF BUSINESS.

OUR GO TO GUY FOR SUPPLY CHAIN ISSUES.

THE IMPACT OF FIRES ON SUPPLY CHAINS IN GENERAL.

>> ONE OF THE BIG PROBLEMS -- ONE THING, THIS IS THE MOST EXPENSIVE FIRE OF ALL-TIME PROBABLY.

CERTAINLY A HUGE PROBLEM IS LOS ANGELES, WHICH IS A VERY IMPORTANT, THE MOST IMPORTANT PORT IN THE U.S. IS WAY MORE IMPORTANT RIGHT NOW BECAUSE OF PROBLEMS ON THE EAST COAST, YOU KNOW, WE ARE WAITING TO SEE IF THERE WILL BE A STRIKE AGAIN.

L.A. IS MORE IMPORTANT THAN EVER.

SOME TRUCK DRIVERS SAY, I'M NOT DRIVING TO L.A., I DON'T WANT TO DO THAT.

THERE ARE HUGE PROBLEMS IN THE SHORT-TERM.

WE COULD SEE THE LONG-TERM PROBLEMS ARE WORST.

>> YOU MENTIONED THE WATER LEVELS ARE LOW AT THE CANAL?

>> YES, THEY HAVE BEEN LOW FOR A WHILE.

THERE IS POLITICAL UNCERTAINTY.

LOCK FEES ARE GOING UP LIKE CRAZY.

THE PORT OF L.A., VOLUMES THIS PAST YEAR FOR 2024 UP FOR 12%.

IT COMES IN THESE DAYS.

>> WHAT DO WE EXPECT REGARDING DELAYS IN THE SHORT-TERM, ESPECIALLY IN ARIZONA.

>> SO FAR, IT'S FUNCTIONING WELL.

THE PROBLEM IS AS YOU GET OUT OF THERE.

THERE IS SOME RAIL SLOWDOWNS AND YOU KNOW, PROBLEMS WITH TRUCKS AND REROUTING AND LIKELY TO BE MORE CONGESTION.

THERE IS CONGESTION ONE WAY OR THE OTHER.

THE PORT IS DOWN A LITTLE BIT FROM ALTIDINA AND THE AREA WHERE THE PALISADES ARE.

L.A. IS A BIG TOWN BUT ALSO SEVERED A SMALL TOWN.

ALL ROADS ARE CONNECTED.

>> THE TRANSPORTATION ISSUES MUST BE OUTRAGEOUS AND GETTING WORST.

>> HUGE SLOWDOWNS.

THAT WON'T COME BACK RIGHT AWAY.

>> FOLKS RIGHT NOW, A LOT OF FOLKS.

IS THERE A LABOR ISSUE HERE AS FAR AS SUPPLY CHAIN.

>> HOW COME WE HAVE BEEN ABLE TO READ INFLATION A BIT.

IT'S A LOT BECAUSE OF OUR ACCESS ENERGY.

REPUBLICANS ARE FOR THAT AND DEMOCRATS DON'T WANT TO DRILL ANYWHERE ELSE.

ON THE OTHER SIDE, THE INFLUX OF LABOR WE ARE GETTING ACROSS THE BORDER, OTHER PLACES AS WELL, THAT'S ALSO REDUCED INFLATION.

IT'S HARDER BECAUSE FOR ONE THING IT'S LESS AFFORDABLE.

THEY ARE PEOPLE WHO HAVE OTHER THINGS GOING ON.

>> WHERE TO LIVE.

POWER OUTAGES IN THE LOS ANGELES AREA.

SUPPLY CHAIN ISSUES AS WELL.

>> ABSOLUTELY.

COMPUTER SYSTEMS HAVE BEEN DOWN.

THERE IS GOOD BACK-UPS IN GENERAL, YOU CAN'T SUFFER TRAUMA LIKE THIS AND HAVE IT WORK IMMEDIATELY WE WANT TO FARTHER THE AREA AND THERE IS AN EFFECT HERE.

>> SO, THE SHORT-TERM IMPACT IS BIG BUT I THINK THE LONG-TERM IMPACT WILL BE HARDER.

FOR ONE THING, THINK ABOUT THE SUCKING OF THE CONSTRUCTION COSTS AND THEY ARE ALL READY TOO HIGH.

WE ARE LIKELY IN THE NEXT FOUR YEARS TO BE TOUGHER ABOUT THINGS ACROSS THE BORDER.

REMEMBER HOW MUCH INFLATION WENT UP WHEN WE STOPPED CANADIAN LUMBER FROM COMING IN.

WE WILL SEE, I MEAN, THIS IS THE MOST EXPENSIVE FIRE EVER.

>> ARE THERE PARTICULAR SECTORS THAT WILL BE ESPECIALLY HIT?

>> WELL, CONSTRUCTION, IT WILL BE GREAT BUT ALSO BE MORE EXPENSIVE.

I THINK, HOUSING WILL BE REALLY TOUGH.

PLACES TO PUT PEOPLE DOWN THERE ARE LIMITED.

THIS IS A BIG HIT.

>> HOW MUCH OF THE HIT WILL WE EXPERIENCE IN ARIZONA.

>> IT WILL PROBABLY BE GOOD FOR US IN ARIZONA.

WE WILL SEE BUSINESSES, WE WILL SEE PEOPLE COMING OVER HERE.

I MEAN, MAYBE SOME PEOPLE IN ARIZONA DON'T WANT PEOPLE COMING HERE.

OVERALL, I DON'T THINK IT WILL BE BAD FOR US.

PEOPLE WILL SAY, MAN, I HAVE BEEN THINKING ABOUT THE COST IN CALIFORNIA AND MOVING DISTRIBUTION CENTER, OFFICE, OR WHATEVER.

THIS COULD BE ANOTHER REASON TO GET OUT OF CALIFORNIA.

>> ARE THERE LESSONS TO BE LEARNED WHEN IT COMES TO SUPPLY CHAIN ISSUES IN TERMS OF I DIDN'T SEE THAT COMING OR SHOULD HAVE SEEN THAT COMING.

>> THE RESPONSE HAS BEEN PRETTY GOOD.

THEY ARE COMING OUT OF THE PANDEMIC.

YOU HAD SOME A LITTLE BIT OF THAT.

REALLY, ALL BIG COMPANIES KNOW HOW TO HANDLE AN EMERGENCY.

KATRINA IS NOW 20 YEARS AGO.

WE REALLY GOT BETTER AT EMERGENCY MANAGEMENT.

>> ENCOURAGING WORDS THERE.

DALE ROGERS W.P.

CAREY SCHOOL OF BUSINESS.

>>> A RESPIRATORY VIRUS SPREADING ACROSS CHINA AND INDIA IS MAKING FOR CONCERNS HERE IN THE U.S.

THE VIRUS IS KNOWN AS HMPV AND WE'RE SEEING AN INCREASE IN CASES HERE IN THE SOUTHWEST.

TO TELL US MORE, WE WELCOME FORMER STATE HEALTH-DIRECTOR WILL HUMBLE, EXECUTIVE DIRECTOR OF THE ARIZONA PUBLIC HEALTH ASSOCIATION.

>> WILL, GOOD TO HAVE YOU.

WHAT IS HMPV?

>> MOST PEOPLE HAVE NEVER HEARD OF THIS VIRUS.

IT'S LIKE RSV.

MOST PEOPLE HAVE HEARD OF RSV.

IT'S IN THE SAME FAMILY AS RSV.

IT'S CAUSING SIMILAR SYMPTOMS.

IT'S LIKE A REALLY BAD COLD VIRUS THAT CREATES A LOT OF CONGESTION.

NOT NECESSARILY FEVER BUT A LOT OF HEAD CONGESTION.

ALSO IN THE LUNGS TOO.

THAT'S WHY IT COULD BE DANGEROUS FOR THE SAME PEOPLE WE HAVE BEEN TALKING ABOUT.

PEOPLE MY AGE AND OLDER, LITTLE KIDS.

PEOPLE WITH OTHER KINDS OF RASPATORY PROBLEMS AND CAUSE PNEUMONIA.

>> IT'S GOING AROUND, ISN'T IT.

>> IT IS.

IT'S NOT REPORTABLE LIKE INFLUENZA.

THE DATA IS NOT GREAT.

THERE ARE LABS THAT VOLUNTARILY TURN IN DATA FROM THE SPECIMENS THEY TEST.

THAT'S THE DATA I PUT-UP ON THE BLOG.

YOU CAN SHOW IN THE WESTERN U.S.

IT'S GOING UP ALLOT.

THIS IS NOT JUST CHINA BE HERE TOO.

SPECIAL PEOPLE ARE TALKING ABOUT IT BECAUSE IT WAS THE FIRST EPIDEMIC IN BEIJING.

>> WE SHOULDN'T SAY NO-NO TO THIS IN THIS ONE.

>> IT'S NO DIFFERENT FROM RSV.

THIS DOESN'T HAVE A VACCINE.

YOU TRY TO PREVENT PEOPLE FROM GETTING PNEUMONIA AND SUPPORTIVE CARE.

>> I HEARD ABOUT COMPLICATIONS.

I ALSO HEARD EAR INFECTIONS.

>> THE CONGESTION IN YOUR HEAD.

IT GETS IN YOUR TUBES.

THAT'S RELATED TO THAT.

>> HOW CONTAGIOUS?

>> IT'S LIKE RSV.

DROPLETS, IF SAME KIND OF THING.

NOT ROCKET SCIENCE.

>> I READ MEASLES AND MUMPS.

>> THE SYMPTOMS ARE DIFFERENT.

>> NOT THE SYMPTOMS BUT THE VIRUS ITSELF.

>> IT IS SIMILAR BUT NOT AS CONTAGIOUS.

MEASLES IS SUPER CONTAGIOUS.

>> I MIGHT HAVE MISREAD THAT.

WE HEARD A LOT ABOUT RSV.

COULD THAT BE HELPFUL AGAINST THIS?

>> NO IT'S TOO DIFFERENT.

THE ANTIGENS ARE TOO DIFFERENT.

>> SAM FAMILY BUT THEY DON'T TALK TO EACH OTHER, IS THAT WHAT YOU ARE TELLING ME?

>> WILL IT BECOME MORE PREVALENT IN THE U.S. OVER THE WINTER, DO YOU THINK?

>> IT'S ALL READY BASED ON THE LIMITED DATA YOU HAVE.

IT'S HARD TO TELL.

I THINK THIS WILL RUN THROUGH THE COUNTRY AND LIKE WE SPOKE ABOUT LAST YEAR.

RSV WAS OFF THE CHARTS LAST YEAR, REMEMBER THAT.

>> THIS YEAR, I MEAN THERE IS SOME RSV OUT THERE, WHY?

PEOPLE WERE INFECTED LAST YEAR AND GIVING YOU RESEIZIAL ANTIBODIES.

WE WILL SEE LESS OF IT.

PEOPLE HAVE PROTECTION NATURAL IMMUNITY.

>> IN TERMS OF HOSPITALIZATION COMPARED TO COVID-19 AND THE FLU?

>> WE DON'T HAVE ENOUGH DATA TO SAY.

IT'S NOT REPORTABLE.

WE ARE GETTING SPORADIC REPORTING.

YOU CAN GET THE BASICS OF IT BUT YOU CAN'T ESTABLISH A TIME BETWEEN THIS AND HOSPITALIZATIONS.

WITH INFLUENZA YOU DEFINITELY SAW AN INCREASE.

>> IT SEEMS LIKE IT'S STARTING TO PICK UP.

>> IT IS.

IT HAS BEEN PICKING UP A LOT SINCE DECEMBER.

LIKE PROCRASTINATORS, IT'S PRETTY MUCH TOO LATE.

INFLUENZA, NOT RSV.

>> HMPV IS NOT GOING GANGBUSTERS LIKE THE FLU.

>> YOU JUST DON'T KNOW.

CAN'T WE DO A BETTER JOB OF THAT?

>> IT'S NOT REPORTABLE.

WE HAVE TO MANDATE REPORTING TO GET PEOPLE TO TURN THE DATA IN.

YOU WILL ALSO NEED, YOU SHOULDN'T REPORT FOR REPORTING SAKE.

IT IS IMPORTANT TO MAKE SURE YOU ASK PEOPLE FOR THINGS YOU NEED.

FOR DATA SAKE IT'S NOT A GOOD POLICY.

>> WE ASK FOR WHAT YOU NEED AND I'M NOT SURE WE ARE IN THE STAGE TO MAKE THIS A REPORTABLE ILLNESS.

TIME WILL TELL, SO FAR, THE DATA IS PICKING UP THE INCREASE IN HOSPITALIZATIONS FROM INFLUENZA.

FROM RSV AND NOT COVID-19.

>> BIRD FLU CASES AND THE CDC PUT AN ALERT OUT ON BIRD FLU CASES BECAUSE THERE WERE PEOPLE THAT TESTED POSITIVE AND NO KNOWN EXPOSURE.

>> YEAH, FOR SURE.

ALSO AN OCCUPATIONAL THING.

>> PEOPLE WORKING IN THE DAIRY INDUSTRY OR BIRD FLOCKS AND THAT KIND OF STUFF.

THEY ARE THE FOLKS MOST EXPOSED.

I THINK THAT'S BACKYARD FLOCKS.

PEOPLE WHO HAVE BACKYARD CHICKENS THEY WERE CLEANING IN THE KITCHEN AND ENDED UP IN THE SEWER AT THAT POINT.

>> YOU HAVE COME ALL THIS WAY AND WE HAVEN'T MENTIONED COVID-19 SPECIFICALLY?

>> IT'S LESS THAN WHAT IT WAS THIS TIME LAST YEAR.

WE HAD A SIZABLE INFECTION AMOUNT LAST YEAR GIVING PEOPLE RESIDUAL IMMUNITY.

ALSO PEOPLE, WHETHER YOU HAVE BEEN INFECTED OR VACCINATED OR NOT MULTIPLE TIMES SOME OF THEM.

I HAD SIX VACCINES AND STILL GOT THE ILLNESS ONE.

THAT IMMUNITY IS BEGINNING TO CONTINUE TO BUILD.

BY THE WAY, COVID-19 DROPPED WAY DOWN IN CAUSES OF DEATHS.

IT WAS THE LEADING CAUSE OF DEATH BUT THIRD LEADING CAUSE OF DEATH.

KNOCKED BELOW 15.

>> KEEP AN EYE ON HMPV.

WILL FROM THE ARIZONA HEALTH ASSOCIATION.

>> MY PLEASURE.

♪ >>> THE MAYO CLINIC HAS ANNOUNCHED A NEW TREATMENT THAT COULD IMPROVE SURVIVAL RATES IN OLDER PATIENTS WITH GLIOBLASTOMA, A PARTICULARLY LETHAL FORM OF BRAIN CANCER.

DOCTOR SUJAY VORA, IS A RADIATION ONCOLOGIST WITH ARIZONA MAYO CLINIC.

HE IS JOINING US NOW.

THANK YOU FOR JOINING US.

>> THANK YOU FOR HAVING ME.

GLIOBLASTOMA.

>> IT'S A BRAIN CANCER THAT ORIGINATES IN THE BRAIN TISSUE ITSELF VERSES MED STATIC CANCER THAT MOVES TO THE BRAIN.

IT EFFECTS 50,000 PATIENTS PER YEAR.

THE INCIDENT HAS INCREASED AS OUR PATIENT POPULATION CONTINUES TO AGE.

>> WHY IS IT SO LETHAL AND AGGRESSIVE?

>> A FEW THINGS, ONE IS DETENTION.

WE DON'T HAVE A SCREENING METHOD FOR FINDING GLIOBLASTOMA.

THEY EITHER HAVE A MEDICAL ISSUE AND THEN WE FIND IT.

THE NEXT CHALLENGE IS OPERATING ON THE PATIENTS.

>> YES.

>> THE TUMORS HAVE TENTACLES INTO HEALTHY BRAIN TISSUE.

>> IT'S DIFFERENT WHEN YOU CAN DO A LARGE SURGERY TO GET AROUND THE CANCER.

THE SURGEONS HAVE TO TAKEOUT AS MUCH AS THEY CAN SAFELY THAN LEAVING THE PATIENTS WORST OUT.

>> THAT'S WHERE THE MAYO CLINIC IS DEALING WITH THE NEW TREATMENT.

>> WE CONTINUE TO SEE RADIATION AND CHEMO THERAPY.

THERE ARE MANY COURSES OF TREATMENT.

WHAT WE FOUND PARTICULARLY IN OLDER PATIENTS MANY TIMES THERE ARE OTHER MEDICAL CONDITIONS THEY HAVE.

THE SURVIVAL RATE OVER THE AGE OF 65 OR 70 IS IN THE SIX TO NINE MONTH RANGE.

WE COME UP WITH A BETTER WAY TO TREAT THE PATIENTS AND COMBINING A FEW DIFFERENT TECHNIQUES.

WE WANTED TO SEE IF WE SEE THE CANCER BETTER WITH ADVANCE MEDICAL IMAGING CALLED A PET SCAN.

THEY USE A THERAPY THAT ALLOWS US TO SHIELD THE HEALTHY BRAIN TISSUE.

WE TRY TO REDUCE THE BURDEN AND FINISH THE RADIATION MUCH FASTER OR FOR ONE TO TWO WEEKS.

THE COMBINATION APPROACH SHOWED RESULTS THAT WERE BETTER THAN EXPECTED.

>> SO BASICALLY, IDENTIFY WHAT'S GOING ON AS WEST YOU CAN AND SPIDER WEBS.

THERE ARE PROTON BEAMS.

ONE PART YOU KNOW YOU CAN GET.

>> THE PROTON THERAPY AS A HEAVIER PARTICLE YOU DIAL-UP THE ENERGY AND GO THE DISTANCE INTO THE BRAIN TISSUE.

DROPS INTO THE TARGET AND RADIATION AFTER THAT.

THAT'S COMPARED TO STANDARD RADIATION.

IT'S MUCH LESS EXPOSURE.

ALL PATIENTS IN PARTICULARLY OLDER PATIENTS.

>> YOU MENTIONED RADIATION TREATMENT, THAT WAS WHAT WAS DONE PRIOR TO THIS.

>> IT'S A DIFFERENT TYPE OF RADIATION THAT ALLOWS US TO SHIELD MUCH MORE OF THE HEALTHY BRAIN TISSUE.

>> A SNIPER AS OPPOSED TO AN ELEPHANT GUN.

>> THIS IS CALLED A SHORT COURSE THERAPY, WHAT DOES THAT MEAN?

>> STANDARD COURSES ARE BETWEEN 3 AND 6 WEEKS.

IN THE SHORT COURSE APPROACH.

DO RADIATION IN ONE TO TWO WEEKS.

MET EASIER ON PATIENTS AND FAMILIES.

WE ALSO HAD PATIENTS IN RURAL AREAS TO ACCESS HEALTHCARE WITH LESS BURDEN ON THEIR FAMILIES.

>> SAY THERE ARE FIRE TENTACLES.

YOU HAVE ONE, CAN YOU GO AFTER TWO, THREE, FOUR, AND FIVE.

IS THERE A LIMIT?

>> WE TRIED TO TREAT THE DISEASE AT THE SAME TIME.

EVERY PLACE WE THINK THERE IS CANCER WE WANT TO COVER THAT.

WE RUN INTO SITUATIONS, UNFORTUNATELY, THEY CAN COME BACK DESPITE OUR BEST TREATMENTS.

THERE ARE TIMES WE HAVE TO COME BACK A SECOND TIME WITH RADIATION, SURGERY, OR NOVEL TYPE OF CHEMO THERAPY.

>> SURVIVAL RATE OF 22 MONTHS.

SO THE STUDY FOCUSED ON OLDER PATIENTS.

AVERAGE SURVIVAL IS 6 TO 9 MONTHS.

IN OUR PATIENTS IT'S 13 MONTHS AND POPULATION OF THOSE PATIENTS THAT HAD MORE FAVORABLE GENERICS.

>> THIS ALLOWS PEOPLE TO DO THINGS.

RESPONSE SO FAR, I MEAN, IT SOUNDS LIKE A SUCCESS.

WHAT'S NEXT AS FAR AS THE STUDY AND TESTING.

>> WITH THESE RESULTS WE ARE ASKING THE QUESTION IS THIS A GOOD IDEA FOR ALL PATIENTS WITH GLIOBLASTOMA.

WE ARE DOING THIS FOR ALL PATIENTS AND HOW MUCH WE ARE BENEFITING THOSE PATIENTS.

IT'S FOUR TIMES LARGER.

>> CONTINUED SUCCESS.

DOCTOR SUJAY VORA THIS IS WASHINGTON SENATOR JOHN McCAIN HAD SOUNDS LIKE A GOOD THING.

>> IT'S PROGRESS.

>> THAT'S IT FOR NOW.

I'M TED SIMONS.

THANK YOU FOR JOINING US.

HAVE A GREAT